US 8853160
GLP-1, exendin-4, peptide analogs and uses thereof
granted A61KA61K38/00A61K38/2278
Quick answer
US patent 8853160 (GLP-1, exendin-4, peptide analogs and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61K38/2278, A61K38/26, A61P